Clinically, GBA1-PD has been linked to a more severe disease phenotype with younger age of onset, increased neuropsychiatric symptoms, hallucinations, autonomic dysfunction, and cognitive decline [7,8,9]. This evidence concerns the gene GBA1 and Parkinson disease.